GU and hospital-based oncology @UCSFCancer 👉patient decision-making support and survivorship
Joined September 2019
- Tweets72
- Following59
- Followers172
- Likes201
Daniel Kwon MD retweeted
🎉 Great work @Kevin_Reyes650, @danielkwonmd and team describing the decision-related needs of people newly diagnosed with #cancer while hospitalized. Multiple perspectives included: patients, caregivers, oncologists.
Check it out: pubmed.ncbi.nlm.nih.gov/3868…
@UCSFCancer @UCSFDHM
Daniel Kwon MD retweeted
So excited for @UCSFMedicine 1st year medical student Joy Huang who is an amazing researcher! I’m lucky to have connected with her. 🙌🍀 #ASCO23
Daniel Kwon MD retweeted
Skeletal-related events after abiraterone or enzalutamide in patients with #mCRPC: a population-based study using the SEER-Medicare Linked Dataset. #BeyondTheAbstract with @danielkwonmd @UCSFCancer on UroToday > bit.ly/3gO41cw @UrolOncol @mbucknor @HalaBorno
A collaborative effort between UCSFs Cancer Genetics and Prevention Program and GU Medical Oncology. @UCSFCancer
A hybrid oncologist/genetic counselor–delivered model is a feasible for high-volume #germlinetesting in men w #prostateCancer #pcSM (both in person & via #telehealth 💻); it does not eliminate racial disparities in testing access however. 👉 fal.cn/3vqSW @danielkwonmd
Daniel Kwon MD retweeted
Skeletal-related events after abiraterone or enzalutamide in patients with #mCRPC: a population-based study using the SEER-Medicare Linked Dataset. #BeyondTheAbstract with @danielkwonmd @UCSFCancer on UroToday > bit.ly/3gO41cw @UrolOncol @mbucknor @HalaBorno
Daniel Kwon MD retweeted
Skeletal-related events after abiraterone or enzalutamide in patients with #mCRPC: a population-based study using the SEER-Medicare Linked Dataset. #BeyondTheAbstract with @danielkwonmd @UCSFCancer on UroToday > bit.ly/3gO41cw @UrolOncol @mbucknor @HalaBorno
Thanks @cancerGRACE for producing this 7-part series I did with Fred on high quality decision making in advanced prostate ca. We talk about why this is important, steps, and resources. Applicable to all cancers! youtube.com/playlist?list=PL…
In this video from our past year's Patient Education Ambassador Program, Dr. @danielkwonmd & Fred discuss his first option: starting hormone treatment immediately and its risks/benefits.
youtu.be/LfcavTfXBiQ
#prostatecancer #cancer #exelixis #lilly #genentech #hormonetherapy
In this @JAMAOnc Patient Page, we (@AnaVManana @ivandk3) wrote an easy-to-understand explanation of PSMA PET Scans in prostate cancer. jamanetwork.com/article.aspx… Great resource for patients. @cancerGRACE
Daniel Kwon MD retweeted
It's rough to wait so long to get 177Lu-PSMA-617 therapy available, and then see a patient who is in such need with a scan that would suggest great benefit (SUVs in the 60s), and then find out that doses can't be delivered for an unknown amount of time. Unbelievable!
Daniel Kwon MD retweeted
Finally! FDA approves 177Lu-PSMA-617. Somewhat odd name (Pluvicto). Can't wait to see the prescribing information.
Daniel Kwon MD retweeted
COVID‐19 outcomes in patients with cancer: Findings from the University of California health system database | @danielkwonmd @FranklinHuang in the journal Cancer Medicine onlinelibrary.wiley.com/doi/… #openaccess
Daniel Kwon MD retweeted
Hey #oncologists and @HemOncFellows! We’re recruiting a new @UCSFHospitals hospital-based oncologist (#HBO)! Come join our growing inpatient solid onc group w @danielkwonmd and me @UCSFCancer 🥰
Apply: bit.ly/HBOfacultyrecruit
Why I ❤️ #HBO: bit.ly/HBOtheOncologist
🩺🥼🏥🥰
Daniel Kwon MD retweeted
mercurynews.com/2022/02/03/8… thanks to the Mercury News for publishing my reflection on what doctoring has taught me about processing the irreplaceable losses of the pandemic.
Daniel Kwon MD retweeted
Hiring AHP (NP/PA) for @UCSFCancer hospital-based oncology #HBO service! Internal and external AHPs welcome: bit.ly/UCSFNPint bit.ly/UCSFNPext bit.ly/UCSFPAint bit.ly/UCSFPAext
Work w sweet (@danielkwonmd) and sassy (🙋🏻♂️) attendings 😝 @UCSFHospitals
Daniel Kwon MD retweeted
Two years into the #COVID19 pandemic & we are still worrying about all the missed #hemeonc fellow professional & career development opportunities!
Excited to see our work in @JCOOP_ASCO ascopubs.org/doi/full/10.120…
highlighting PD #burnout & perspectives on #fellowship needs
Thanks for highlighting our work. @UCSFCancer
A mobile application for pts to record consults was feasible, acceptable, and a potentially valued intervention to improve decision making in the #telehealth setting for men w/ #prostatecancer. fal.cn/3l9BG #pcsm #JCOOP @danielkwonmd
Daniel Kwon MD retweeted
A mobile application for pts to record consults was feasible, acceptable, and a potentially valued intervention to improve decision making in the #telehealth setting for men w/ #prostatecancer. fal.cn/3l9BG #pcsm #JCOOP @danielkwonmd
Great work by @WaspGarrett. Used consultation audio recordings of pt-oncologist visits to find that when discussing systemic tx, default is to continue tx, 2/2 deficiencies in shared decision making. What can be done? ascopubs.org/doi/abs/10.1200…
Need to increase our visit times, implement communication tools like consultation recordings, decision tools like decision aids and question prompt lists, and make sure our workforce has adequate, culturally competent communication training. @JCOOP_ASCO
Daniel Kwon MD retweeted
Thank you @JournalCancer for highlighting work with @danielkwonmd @HemoncUcsf of outcomes in mCRPC patients with DDR mutations, a multi-institutional effort @UCSFCancer @UCSFMedicine @UMRogelCancer @UBCmedicine @PCFnews @PCF_Science
Read our June 15 issue today! 📗
acsjournals.onlinelibrary.wi…
In this issue:
➡️ @koshkin85 et al on differential tx outcomes in mCRPC
➡️ @BrainMets_MSK investigators on MBMs in the age of adv treatments
➡️ @DrFadloKhuri's reflection on the past 10 years as our Editor-in-Chief
